Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Octenidine + prednicarbate cream vs mono-substances in candida intertriginous infections
2009-016627-56Phase 2Completed
- Sponsor
- Almirall
- Start
- Oct 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in candidiasis and cutaneous candidiasis comparing Octenidine + prednicarbate combination cream, Octenidine monotherapy cream and Prednicarbate monotherapy cream (3 arms). Primary endpoint: Treatment success. Started Oct 2009; status: completed.
02
Drugs
octenidineprednicarbate
03
Conditions
candidiasiscutaneous candidiasis
Beyond the preview
Go deeper on 2009-016627-56.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016627-56.